[135 cases of polymyositis].

Area of Science:

• Neurology
• Rheumatology
• Immunology

Context:

• The classification of inflammatory myopathies, specifically dermatomyositis (DM) and polymyositis (PM), presents diagnostic challenges.
• A study analyzed 135 patients diagnosed with DM or PM, examining clinical presentations, diagnostic test results, and pathological findings.

Purpose:

• To evaluate the effectiveness of current classification systems for dermatomyositis and polymyositis.
• To identify limitations in distinguishing between DM and PM and their subtypes.
• To explore the diagnostic utility of various tests and pathological markers.

Summary:

• The study reviewed 135 cases of DM and PM, noting the distribution of subtypes including adult DM/PM, cancer-associated DM, juvenile DM, localized PM, and overlapping syndromes.
• Biological tests (ESR, serum enzymes) showed inconsistent abnormalities. Electromyography (EMG) typically indicated myogenic changes with spontaneous activity in half the cases.
• Muscle biopsy findings varied, with inflammation, necrosis, and regeneration observed, but perifascicular atrophy was only reported in 21 patients. Normal biopsies occurred in some cases.
• Current classification systems were deemed unsatisfactory, highlighting the poorly defined distinctions between acute DM and subacute/chronic PM, and the frequent overlap between these conditions.
• The study suggests polymyositis may be a syndrome, and pseudo-myasthenic/myopathic forms are not distinct entities. Associations with other connective tissue diseases are common.

Impact:

• Highlights the need for improved diagnostic criteria for DM and PM to enhance clinical management and research.
• Suggests a re-evaluation of polymyositis as a distinct entity versus a syndrome.
• Underscores the variability in diagnostic test results and biopsy findings, emphasizing the complexity of these autoimmune diseases.